Understanding Rheumatoid Arthritis Pathophysiology

Sep 14, 2024

Rheumatoid Arthritis Lecture Notes

Introduction to Rheumatoid Arthritis

  • "Arthr-" refers to joints; "-itis" means inflammation.
  • "Rheumatoid" comes from rheumatism, a musculoskeletal illness.
  • Chronic inflammatory disorder mainly affecting joints and possibly other organ systems (skin, lungs).

Anatomy of a Healthy Joint

  • Two bones covered with articular cartilage.
  • Articular cartilage: protective cushion for smooth movement.
  • Synovial Joint:
    • Connects two bones with fibrous joint capsule (continuous with periosteum).
    • Lined with synovial membrane producing synovial fluid.
    • Synovial fluid: jelly-like lubricant to reduce friction.
    • Membrane contains blood vessels and lymphatics.

Pathophysiology of Rheumatoid Arthritis

  • Autoimmune Process:

    • Triggered by genetic factors (e.g., HLA-DR1, HLA-DR4) and environmental factors (e.g., cigarette smoke, pathogens).
    • Modification of self-antigens (e.g., IgG, type II collagen) through citrullination.
    • Immune cells misrecognize modified proteins, leading to autoantibody production.
  • Immune Response:

    • CD4+ T-helper cells activated by antigen-presenting cells.
    • B-cells produce autoantibodies against self-antigens.
    • T-cells secrete cytokines (e.g., interferon-Îł, IL-17) attracting inflammatory cells (macrophages).
    • Macrophages produce cytokines (TNF-α, IL-1, IL-6) stimulating synovial cell proliferation.
  • Pannus Formation:

    • Thick, swollen synovial membrane with granulation tissue.
    • Damages cartilage, soft tissues, and erodes bone.

Mechanisms of Joint Damage

  • Synovial cells secrete proteases breaking down articular cartilage.
  • T-cell surface protein RANKL activates osteoclasts, leading to bone resorption.
  • Autoantibodies (e.g., rheumatoid factor, anti-CCP) form immune complexes activating complement system.

Extra-Articular Manifestations

  • Chronic Inflammation Effects:
    • Angiogenesis increases inflammatory cell influx.
    • Systemic effects from cytokines affecting various organs:
      • Fever (IL-1, IL-6)
      • Rheumatoid nodules (collections of macrophages and lymphocytes)
      • Vasculitis (inflammation of blood vessels)
      • Anemia (due to hepcidin production)
      • Lung fibrosis and pleural effusions.

Clinical Features

  • Symmetric joint involvement (5+ joints, e.g., hands, feet).
  • Commonly affected joints: metacarpophalangeal, proximal interphalangeal.
  • Symptoms during flares: swelling, warmth, redness, pain, stiffness, especially in the morning.
  • Typical deformities:
    • Ulnar deviation of fingers.
    • Boutonniere Deformity: flexion of proximal interphalangeal joint.
    • Swan Neck Deformity: hyperextension of proximal interphalangeal joint.
  • Baker's Cyst: bulging of synovial fluid into the popliteal fossa.

Diagnosis

  • Blood Tests:
    • Presence of rheumatoid factor, anti-CCP.
  • Imaging Studies:
    • X-ray findings: decreased bone density, soft tissue swelling, joint space narrowing, bony erosions.

Treatment and Management

  • Disease-Modifying Antirheumatic Drugs (DMARDs):
    • Methotrexate, hydroxychloroquine, sulfasalazine.
  • Biologics:
    • Abatacept (T-cell suppression), rituximab (B-cell suppression).
    • TNF blockers (adalimumab, etanercept, infliximab).
    • Anakinra (blocks IL-1), tocilizumab (blocks IL-6).
  • Acute Flares:
    • NSAIDs, short-term glucocorticoids.

Summary

  • Rheumatoid arthritis: systemic autoimmune inflammatory disorder.
  • Characterized by joint destruction, elevated rheumatoid factor, and anti-CCP levels.
  • Affects multiple organs including skin, heart, blood vessels, lungs.